Boris Labar

Summary

Affiliation: University Hospital
Country: Croatia

Publications

  1. ncbi request reprint Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation
    Zorana Grubic
    National Referral Organ Transplantation and Tissue Typing Centre, University Hospital Centre Zagreb, Zagreb, Croatia
    Clin Transplant 19:586-90. 2005
  2. ncbi request reprint [Current approach to diagnosis and treatment of acute leukemia in adults]
    Boris Labar
    Zavod za hematologiju, Klinika za unutrasnje bolesti, Klinicki bolnicki centar, Zagreb, Hrvatska
    Acta Med Croatica 62:403-8. 2008
  3. ncbi request reprint Allogeneic stem cell transplantation in treatment of aggressive lymphomas: case series
    Boris Labar
    Division of Hematology, Zagreb University Hospital Center, Kispaticeva 12, Croatia
    Croat Med J 43:565-8. 2002
  4. pmc Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
    Boris Labar
    Department of Hematology University Hospital Center Rebro, Kispatic street 12 1000 Zagreb, Croatia
    Haematologica 95:1489-95. 2010
  5. ncbi request reprint Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial
    Boris Labar
    Department of Hematology, University Hospital Center Rebro, Zagreb, Croatia
    Haematologica 89:809-17. 2004
  6. ncbi request reprint [Diagnosis and therapy for patients with essential thrombocythemia. Guidelines of Croatian Cooperative Group for hematologic disorders--KROHEM]
    Boris Labar
    Klinika za unutrasnje bolesti, Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb
    Lijec Vjesn 132:333-9. 2010
  7. doi request reprint CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma
    Zdravko Mitrovic
    Division of Hematology, Department of Medicine, University Hospital Center and Medical School University of Zagreb, Croatia
    Clin Lymphoma Myeloma 9:133-7. 2009
  8. doi request reprint Prognostic significance of survivin and caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP
    Zdravko Mitrovic
    Division of Hematology and Department of Medicine, University Hospital Center Zagreb and School of Medicine University of Zagreb, Kispaticeva 12, 10 000 Zagreb, Croatia
    Pathol Oncol Res 17:243-7. 2011
  9. doi request reprint Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
    Ivana Ilic
    Department of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia
    Int J Hematol 90:74-80. 2009
  10. ncbi request reprint Biological features and outcome of biphenotypic acute leukemia: a case series
    Mirta Mikulic
    Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
    Hematol Oncol Stem Cell Ther 1:225-30. 2008

Collaborators

Detail Information

Publications48

  1. ncbi request reprint Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation
    Zorana Grubic
    National Referral Organ Transplantation and Tissue Typing Centre, University Hospital Centre Zagreb, Zagreb, Croatia
    Clin Transplant 19:586-90. 2005
    ..The PCR-STR method proved to be a fast and relatively simple method, while the tested STR loci showed a high level of informativeness...
  2. ncbi request reprint [Current approach to diagnosis and treatment of acute leukemia in adults]
    Boris Labar
    Zavod za hematologiju, Klinika za unutrasnje bolesti, Klinicki bolnicki centar, Zagreb, Hrvatska
    Acta Med Croatica 62:403-8. 2008
    ..It is expected that techniques such as gene expression profiling will identify genetic abnormalities and their proteins as a targeted site for new drugs. This might increase the efficacy of leukemia treatment and control...
  3. ncbi request reprint Allogeneic stem cell transplantation in treatment of aggressive lymphomas: case series
    Boris Labar
    Division of Hematology, Zagreb University Hospital Center, Kispaticeva 12, Croatia
    Croat Med J 43:565-8. 2002
    ..To assess the outcome of allogeneic stem cell transplantation in patients with aggressive lymphoma...
  4. pmc Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
    Boris Labar
    Department of Hematology University Hospital Center Rebro, Kispatic street 12 1000 Zagreb, Croatia
    Haematologica 95:1489-95. 2010
    ..Corticosteroids are a standard component of the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma. Our aim was to determine whether dexamethasone results in a better outcome than prednisolone...
  5. ncbi request reprint Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial
    Boris Labar
    Department of Hematology, University Hospital Center Rebro, Zagreb, Croatia
    Haematologica 89:809-17. 2004
    ..In the EORTC ALL-3 trial, the efficacy of allogeneic transplantation was compared with that of autologous marrow transplantation and maintenance chemotherapy in patients <or= 50 years who reached CR...
  6. ncbi request reprint [Diagnosis and therapy for patients with essential thrombocythemia. Guidelines of Croatian Cooperative Group for hematologic disorders--KROHEM]
    Boris Labar
    Klinika za unutrasnje bolesti, Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb
    Lijec Vjesn 132:333-9. 2010
    ..In high risk patients hydroxyurea is the first line treatment. Anagrelide is indicated in these patients in the absence of treatment response. Alpha-interferon is recommended for pregnant women with ET and high platelet counts...
  7. doi request reprint CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma
    Zdravko Mitrovic
    Division of Hematology, Department of Medicine, University Hospital Center and Medical School University of Zagreb, Croatia
    Clin Lymphoma Myeloma 9:133-7. 2009
    ..CD43 is a transmembrane glycoprotein expressed in different hematopoietic cells, including some subsets of B lymphocytes. About a quarter of diffuse large B-cell lymphomas (DLBCLs) express CD43, but its prognostic significance is unknown...
  8. doi request reprint Prognostic significance of survivin and caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP
    Zdravko Mitrovic
    Division of Hematology and Department of Medicine, University Hospital Center Zagreb and School of Medicine University of Zagreb, Kispaticeva 12, 10 000 Zagreb, Croatia
    Pathol Oncol Res 17:243-7. 2011
    ..The expression of caspase-3 was also not associated with patients' outcome. We conclude that survivin and caspase-3 have no significant prognostic significance in patients with DLBCL treated with R-CHOP...
  9. doi request reprint Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
    Ivana Ilic
    Department of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia
    Int J Hematol 90:74-80. 2009
    ..The patients of this study with immunohistochemically determined GCB-type DLBCL did not have an improved prognosis, irrespective of whether they had received rituximab or not...
  10. ncbi request reprint Biological features and outcome of biphenotypic acute leukemia: a case series
    Mirta Mikulic
    Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
    Hematol Oncol Stem Cell Ther 1:225-30. 2008
    ..Our objective was to analyze the biological features and outcome of patients diagnosed with BAL in our institution...
  11. ncbi request reprint Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease
    Igor Aurer
    Division of Hematology, Department of Internal Medicine, University Hospital Center Rebro and Medical School, Zagreb, Croatia
    Onkologie 28:567-71. 2005
    ..Patients with refractory Hodgkin's disease or relapsing after high-dose therapy and autografting have a poor prognosis. Here, we present our experiences with gemcitabine in this setting...
  12. ncbi request reprint Post-remission treatment for adult patients with acute lymphoblastic leukemia in first remission: is there a role for autologous stem cell transplantation?
    Roel Willemze
    Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands, and University Hospital Center Rebro, Zagreb, Croatia
    Semin Hematol 44:267-73. 2007
    ..This finding may eventually have an impact on the overall survival rate. Currently, the main benefit of autoSCT may be its short duration compared with the continuation chemotherapy regimen...
  13. ncbi request reprint FNA based diagnosis of head and neck nodal lymphoma
    Koraljka Gjadrov Kuvezdić
    Department of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia
    Coll Antropol 34:7-12. 2010
    ..Based on our results FNA corroborated with immunophenotyping by immunocytochemistry can be method of choice in primary lymphoma diagnosis as a method complementary to histopathology in lymphoma diagnostics...
  14. ncbi request reprint [Rituximab in the treatment of indolent non-Hodgkin's lymphoma]
    Igor Aurer
    Zavod za hematologiju, Klinika za unutarnje bolesti Medicinskog fakulteta i Klinickoga bolnickog centra, Zagreb
    Lijec Vjesn 126:307-11. 2004
    ..Adverse effects related to rituximab occurred in 2 patients and were mild. Our results are completely comparable to previously reported studies and show that rituximab is effective and safe for the treatment of indolent B-cell NHL...
  15. ncbi request reprint [Treatment of acute leukemia with allogeneic stem cell transplantation]
    Ranka Serventi Seiwerth
    Zavod za hematologiju, Klinika za unutarnje bolesti, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 63:205-8. 2009
    ..Since that time, 281 patients with acute leukemia have undergone allotransplantation at our Department. Results are presented of 72 patients with acute myeloid leukemia transplanted at our Department during the 1993-2007 period...
  16. ncbi request reprint Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study
    Ivo Radman
    Division of Hematology, Department of Medicine, Zagreb University Hospital Center and School of Medicine, Kispaticeva 12, Croatia
    Croat Med J 43:555-60. 2002
    ..To evaluate the role of surgical resection in the treatment of patients with primary gastrointestinal non-Hodgkin s lymphoma in our institution...
  17. ncbi request reprint [Twenty years of severe aplastic anemia treatment at Department of Hematology, University Department of Medicine, Zagreb University Hospital Center, Zagreb, Croatia]
    Mirando Mrsic
    Zavod za hematologiju, Klinika za unutrasnje bolesti, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 63:209-14. 2009
    ..Infection is the main cause of death in both groups. In conclusion, we documented improving results using ATG in patients with SAA...
  18. ncbi request reprint The value of F-18 FDG triple-head coincidence PET in the posttreatment evaluation of patients with lymphoma
    Drazen Huic
    Department of Nuclear Medicine and Radiation Protection, Division of Haematology, Zagreb University Hospital Centre, Zagreb, Croatia
    Clin Nucl Med 31:275-8. 2006
  19. ncbi request reprint Collection and composition of autologous peripheral blood stem cells graft in patients with acute myeloid leukemia: influence on hematopoietic recovery and outcome
    Mirela Raos
    Department of Transfusion Medicine and Cellular Therapy, University Hospital Center Zagreb, Zagreb, Croatia
    Coll Antropol 34:105-15. 2010
    ..These advantages could provide their standard application in the treatment of patients with AML...
  20. ncbi request reprint FCgammaRIIIA and FCgammaRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma
    Zdravko Mitrovic
    Division of Hematology, Department of Internal Medicine, University Hospital Center and Medical School University of Zagreb, Croatia
    Haematologica 92:998-9. 2007
    ..These results suggest that ADCC via FcgammaRIIIa and FcgammaRIIa may not be the major mechanism of activity of the R-CHOP combination in DLBCL...
  21. ncbi request reprint Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study
    Igor Aurer
    Division of Hematology, Department of Medicine, Zagreb University Hospital Center, Kispaticeva 12, Croatia
    Croat Med J 43:550-4. 2002
    ..Our aim was to evaluate retrospectively the results of this treatment in our institution...
  22. doi request reprint Large volume leukapheresis: Efficacy and safety of processing patient's total blood volume six times
    Ines Bojanic
    Department of Transfusion Medicine and Cellular Therapy, University Hospital Centre Zagreb, Kispaticeva 12, Croatia
    Transfus Apher Sci 44:139-47. 2011
    ..Although a marked platelet decrease can be expected, LVL is safe and can be recommended as the standard procedure for patients who mobilize low numbers of CD34+ cells and when high number of CD34+ cells are required...
  23. pmc The influence of tumor necrosis factor microsatellite polymorphisms on patient survival following hematopoietic stem cell transplantation
    Katarina Stingl
    Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Center Zagreb, Kispaticeva 12, Zagreb, Croatia
    Croat Med J 53:24-9. 2012
    ..To investigate the influence of tumor necrosis factor (TNF) microsatellite polymorphisms on patient survival following hematopoietic stem cell transplantation...
  24. ncbi request reprint Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis
    Nadira Durakovic
    Department of Internal Medicine, Division of Hematology, Clinical Hospital Center Zagreb, Croatia
    Intern Med 50:1009-13. 2011
    ..The aim of this study was to determine the efficacy and safety of colistin (colistimethate sodium) in the treatment of serious infections caused by MDR-PA in these patients...
  25. ncbi request reprint [World's registry of bone marrow donors]
    Esma Cecuk-Jelicić
    Zavod za tipizaciju tkiva, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 63:251-3. 2009
    ..The current number of donors and cord blood units in the BMDW database is 12,092,374...
  26. ncbi request reprint [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study]
    Dubravka Zupanić-Krmek
    Odjel za hematologiju, Opca bolnica Sveti Duh, Zagreb, Hrvatska
    Acta Med Croatica 58:275-84. 2004
    ..The incidence, outcome and risk factors for developing invasive fungal infection were retrospectively analyzed in 150 patients with acute leukemia during intensive cytostatic therapy...
  27. ncbi request reprint [Treatment of chronic myeloid leukemia with imatinib in the accelerated stage of the disease]
    Josko Bulum
    Zavod za hematologiju, Klinika za unutrasnje bolesti Medicinskog fakulteta, Klinicki bolnicki centar, Kispaticeva 12, 10 000 Zagreb
    Lijec Vjesn 125:176-9. 2003
    ..The most frequent adverse effects were edema, nausea, neutropenia and thrombocytopenia. Imatinib mesylate has a substantial, but short term activity in the accelerated phase and blastic crisis of the Ph+ CML...
  28. ncbi request reprint [Registry of cell and tissue donors]
    Vesna Brkljacić-Kerhin
    Zavod za tipizaciju tkiva, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 61:463-6. 2007
    ..The protocol of compatible graft identification and procedure of graft procurement for transplantation are described. Results recorded at Department of Tissue Typing, Zagreb University Hospital Center since 1983 are presented...
  29. ncbi request reprint [Primary central nervous system lymphoma--a single center experience]
    Zdravko Mitrovic
    Zavod za hematologiju, Klinika za unutarnje bolesti Medicinskog fakulteta, KBC Zagreb
    Lijec Vjesn 129:391-5. 2007
    ..Our results are satisfactory in patients younger than 60 years, especially if treated with high dose methotrexate. Older patients, who represent majority of the patients, have dismal prognosis irrespective of treatment modality...
  30. ncbi request reprint [Cytomorphology of acute mixed leukemia]
    Mirna Sucic
    Zavod za citologiju, Klinicki zavod za patologiju i citologiju, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 62:379-85. 2008
    ..The aim of this study was to compare cytomorphology and immunophenotype of AL to better understand the relation of certain AL morphology, immunophenotype, cytogenetics and molecular biology of biphenotypic AL...
  31. ncbi request reprint [Hematopoetic stem cell bank at Zagreb University Hospital Center, Zagreb, Croatia]
    Branka Golubić Cepulić
    Zavod za klinicku transfuziologiju, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 61:505-9. 2007
    ..At the moment, there are 587 HSC units on stock for 262 patients. In the future, we are planning to establish a public umbilical cord bank and laboratory for cell therapy...
  32. ncbi request reprint Apoptosis of leukemic cells: a case report
    Ljiljana Vrbanus
    Clinical Department of Pathology and Cytology, Zagreb University Hospital Center and School of Medicine, Zagreb, Croatia
    Coll Antropol 34:705-11. 2010
    ....
  33. doi request reprint Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient
    Iva Brcic
    Department of Pathology, Zagreb University Hospital Center, Kispaticeva 12, 10000, Zagreb, Croatia
    Int J Hematol 88:189-91. 2008
    ..Immunohistochemical studies revealed that the tumor cells were positive for CD3, CD34 class II, CD10, CD79a and CD99 but negative for TdT. Even though TdT was negative, he received ALL-therapy and is now in remission...
  34. ncbi request reprint Treatment of multiple relapsing non-melanoma skin cancers in a patient with severe hemophilia A
    Silva Zupancic Salek
    Division of Hematology, University Department of Internal Medicine, Clinical Hospital Center Zagreb, Zagreb, Croatia
    Tumori 95:115-8. 2009
    ..The management of such patients could be very challenging, with possible significant bleeding complications, and requires a multidisciplinary approach...
  35. doi request reprint Malignant epithelial tumors and hematologic malignancy
    Mirjana Marković-Glamocak
    Division of Cytology, Clinical Department of Pathology and Cytology, Zagreb University School of Medicine and Clinical Hospital Center, Zagreb, Croatia
    Diagn Cytopathol 36:710-4. 2008
    ..Most carcinomas were breast cancer (8/10), while prostate and thyroid gland cancer were diagnosed each in one patient, respectively...
  36. ncbi request reprint [Biphenotypic and bilineal acute leukemias]
    Drago Batinic
    Zavod za imunologiju i Referentni centar za imunodijagnostiku imunoloskih i hematoloskih bolesti Ministarstva zdravstva Republike Hrvatske, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 62:387-90. 2008
    ..Collaborative studies are needed for better understanding of the biology of these entities and establishment of standard therapeutic protocols...
  37. ncbi request reprint Splenectomy? No, thank you!
    Drazen Huic
    Department of Nuclear Medicine and Radiation Protection, Zagreb University Hospital Center, Zagreb, Croatia
    Eur J Nucl Med Mol Imaging 31:1677. 2004
  38. ncbi request reprint Management of Gaucher disease in a post-communist transitional health care system: Croatian experience
    Mirando Mrsic
    Division of Hematology, Department of Internal Medicine, Zagreb University Hospital Center, Kispaticeva 12, 10000 Zagreb, Croatia
    Croat Med J 44:606-9. 2003
    ..To evaluate the feasibility of financing the treatment of Gaucher disease with recombinant human imiglucerase in the Croatian health care system...
  39. ncbi request reprint [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation]
    Nikolina Basic-Jukic
    Zavod za hematologiju, Klinika za unutrasnje bolesti, Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 57:131-9. 2003
    ..It is hard to believe that it would be possible to prevent and cure GVHD with a single agent; combination of immunosuppressive drugs that act on different phases of GVHD induction seems promising...
  40. ncbi request reprint [Plasticity of hematopoietic stem cells]
    Boris Labar
    Zavod za hematologiju, Klinika za unutrasnje bolesti Medicinskog fakulteta Sveucilista u Zagrebu i Klinickcog bolnickog centra Zagreb, Zagreb, Hrvatska
    Acta Med Croatica 63:227-30. 2009
    ..Clinical findings will provide information on the underlying mechanism of plasticity and the most applicable model systems...
  41. ncbi request reprint Aberrant glycosylation of Igg heavy chain in multiple myeloma
    Igor Aurer
    Division of Hematology, Department of Internal Medicine, University Hospital Center and Medical School, Zagreb, Croatia
    Coll Antropol 31:247-51. 2007
    ..These data indicate that multiple myeloma is characterized by aberrant immunoglobulin glycosylation...
  42. ncbi request reprint Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
    Stefan Suciu
    European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium
    Blood 102:1232-40. 2003
    ..In younger patients (15-35 years), the difference was more pronounced. The strategy to perform early allo-SCT led to better overall results than auto-SCT, especially for younger patients or those with bad/very bad risk cytogenetics...
  43. ncbi request reprint Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey
    Alois Gratwohl
    Division of Hematology, Department of Internal Medicine, University Hospital Basel, CH 4031 Basel, Switzerland
    Croat Med J 45:689-94. 2004
    ..Another important factor seems to be the access to the therapeutic procedure. These data provide a basis for health care planning...
  44. ncbi request reprint [Characteristics of autologous peripheral blood stem cells in pediatric patients]
    Ines Bojanic
    Zavod za klinicku transfuziologiju, Klinicki zavod za laboratorijsku dijagnostiku, KBC Zagreb
    Lijec Vjesn 128:43-8. 2006
    ..Our results show that leukapheresis in pediatric patients is a safe procedure, well tolerated and with a very low risk of serious adverse events...
  45. ncbi request reprint [Treatment of hairy cell leukemia with cladribine]
    Igor Aurer
    Klinika za unutarnje bolesti Medicinskog fakulteta i Klinickog bolnickog centra Zagreb
    Lijec Vjesn 129:80-3. 2007
    ..There were no significant differences in toxicity and response between 7-day continuous infusion and 5-day intermittent infusions of the drug...
  46. ncbi request reprint Developing a European network for adult ALL
    Nicola Gökbuget
    Medical Department III, Hematology, Oncology, Rheumatology and Infectiology, J W Goethe University Hospital, Frankfurt, Germany
    Hematol J 5:S46-52. 2004
  47. ncbi request reprint Correlations among age, cytokines, lymphocyte subtypes, and platelet counts in autoimmune thrombocytopenic purpura
    Srdana Culić
    Department of Pediatric Hematology, Clinical Hospital Split, 21000 Split, Spinciceva 1, and Institute of Anatomy, Medical School University of Zagreb, Salata, Croatia
    Pediatr Blood Cancer 47:671-4. 2006
    ..Additional evaluations are necessary to identify the impact of age-related changes in immune function on the clinical course of autoimmune thrombocytopenic purpura...
  48. ncbi request reprint Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants
    Mirna Sucic
    Division of Cytology of the Clinical Institute of Laboratory Diagnosis, Zagreb University Clinical Hospital Center and School of Medicine, 10000 Zagreb, Croatia
    J Hematother Stem Cell Res 11:941-50. 2002
    ..On the contrary, lack of detection of PML/RARalpha by RT-PCR at least three times is a sign of long remission and survival...